[What Price Healthcare? RevMed’s Rasonque-The US Drug Pricing Paradox](https://wbbsec.com/opinions-and-features/what-price-healthcare-revmeds-rasonque-the-us-drug-pricing-paradox/)
[What Price Healthcare? RevMed’s Rasonque-The US Drug Pricing Paradox](https://wbbsec.com/opinions-and-features/what-price-healthcare-revmeds-rasonque-the-us-drug-pricing-paradox/)
  •   (858) 592-9901
  •   [email protected]
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute

Opinions & Features

A Charlie Munger Legacy – The Healthy Returns And Health Conundrum

By:WBB SecuritiesPosted: Dec 4th, 2023In: Opinions & Features

Charlie Munger, investing Titan and Warren Buffet’s business partner, passed away on November 28th, a month shy of his 100th birthday. Regardless of one’s opinion of Munger the man, there can be no doubt that[...]

Read More about A Charlie Munger Legacy – The Healthy Returns And Health Conundrum

Even Without A Shutdown – The 5 Healthcare Issues For Speaker Johnson

By:WBB SecuritiesPosted: Nov 15th, 2023In: Opinions & Features

A government shutdown appears to have been averted with the Continuing Resolution passed in the House yesterday. But attention to the existential threat to the U.S. Healthcare System that Congress will inevitably face has[...]

Read More about Even Without A Shutdown – The 5 Healthcare Issues For Speaker Johnson

The CDC faces $1.5 billion in budget cuts. Layoffs will almost certainly follow

By:WBB SecuritiesPosted: Aug 16th, 2023In: Opinions & Features

The nation’s health faces a dual threat — one anticipated, the other, self-inflicted. Covid-19 has not gone away; the Centers for Disease Control and Prevention reports that infections are showing signs of a late summer wave.[...]

Read More about The CDC faces $1.5 billion in budget cuts. Layoffs will almost certainly follow

AI In Healthcare And Other Scary Stories

By:WBB SecuritiesPosted: Jul 7th, 2023In: Opinions & Features

AI being used to discover new drugs and faster, more accurate medical diagnoses are guaranteed clickbait. These goals may be the stuff of dreams, but make no mistake, AI is already here.

Read More about AI In Healthcare And Other Scary Stories

Healthier Uses For The $5 Billion NextGen Covid-19 Funds

By:WBB SecuritiesPosted: Apr 14th, 2023In: Opinions & Features

Paraphrasing a line miscredited to Einstein: “Insanity is repeating the same mistakes and expecting different results.”

Read More about Healthier Uses For The $5 Billion NextGen Covid-19 Funds

The 5 SVB Critical Questions And Answers For Biotech

By:WBB SecuritiesPosted: Mar 11th, 2023In: Opinions & Features

Six months ago, I wrote in Forbes how the Fed’s Inflation fight would harm Biotech. With the FDIC takeover of Silicon Valley Bank (SVB) using the receiver, Deposit Insurance National Bank of Santa Clara the[...]

Read More about The 5 SVB Critical Questions And Answers For Biotech

The Next Covid-19 Crisis, May 11th And Our Missing Healthcare Leadership

By:WBB SecuritiesPosted: Feb 1st, 2023In: Opinions & Features

A looming and avoidable Covid-19 crisis is on the horizon as detailed by Dr. Steve Brozak in a piece breaking today for Forbes. The pandemic emergency declaration is to end May 11 with only “placeholder”[...]

Read More about The Next Covid-19 Crisis, May 11th And Our Missing Healthcare Leadership

7 Covid-19 Realities To Consider In 2023

By:WBB SecuritiesPosted: Dec 31st, 2022In: Opinions & Features

In May 2020, Dr. Rick Bright, former director of BARDA, warned Congress that, without ramped up coronavirus pandemic preparedness, we would face the darkest winter in modern history. His warnings were spot on, however there[...]

Read More about 7 Covid-19 Realities To Consider In 2023

Another Theranos crime: Loss of trust in real-time diagnostics

By:WBB SecuritiesPosted: Dec 8th, 2022In: Opinions & Features

I can’t speak to the appropriateness of the prison time. But I believe that no financial award could come close to equivalency for the irreparable harm the Theranos debacle has done to individual patients, the[...]

Read More about Another Theranos crime: Loss of trust in real-time diagnostics

DIABETES – The Pandemic Is Here. How Do We Treat It?

By:WBB SecuritiesPosted: Nov 8th, 2022In: Opinions & Features

This winter, the United States is facing the “Perfect Storm” of COVID, flu and Respiratory Syncytial Virus (RSV)…

Read More about DIABETES – The Pandemic Is Here. How Do We Treat It?
Load More

Recent News

  • What Price Healthcare? RevMed’s Rasonque—The US Drug Pricing Paradox September 8, 2026
  • New Forbes Article by Dr. Steve Brozak — Is Warren Buffett’s Stock Gambling Warning Bad for Biotechnology? July 21, 2026
  • Dr. Steve Brozak Reviews The Code as Witness in Forbes June 9, 2026
  • Deaths, Burned Clinics—What’s Different About Ebola’s 2026 Return? – Published in Forbes May 25, 2026
  • 5 Urgent Questions After The WHO Emergency Hantavirus Meeting – Published in Forbes May 15, 2026

20 Commerce Dr.
Ste. 135
Cranford, NJ 07016

3111 Camino Del Rio N.
Ste. 400
San Diego, CA 92108

Copyright © 2026 WBB Securities, LLC. All Rights Reserved. Member FINRA/SIPC, BrokerCheck

  • Form CRS
  • Disclosures
  • Privacy Policy
Menu Bottom